Conjunctivitis A Systematic Review of Diagnosis and Treatment

被引:357
作者
Azari, Amir A. [1 ]
Barney, Neal P. [1 ]
机构
[1] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53792 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2013年 / 310卷 / 16期
基金
美国国家卫生研究院;
关键词
ACUTE BACTERIAL CONJUNCTIVITIS; OPHTHALMIC SUSPENSION 0.6-PERCENT; SEASONAL ALLERGIC CONJUNCTIVITIS; TOPICAL LOMEFLOXACIN 0.3-PERCENT; RESISTANT STAPHYLOCOCCUS-AUREUS; 1.5-PERCENT EYE DROPS; CLINICAL-TRIAL; PHASE-III; OLOPATADINE HYDROCHLORIDE; CHALLENGE MODEL;
D O I
10.1001/jama.2013.280318
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Conjunctivitis is a common problem. OBJECTIVE To examine the diagnosis, management, and treatment of conjunctivitis, including various antibiotics and alternatives to antibiotic use in infectious conjunctivitis and use of antihistamines and mast cell stabilizers in allergic conjunctivitis. EVIDENCE REVIEW A search of the literature published through March 2013, using PubMed, the ISI Web of Knowledge database, and the Cochrane Library was performed. Eligible articles were selected after review of titles, abstracts, and references. FINDINGS Viral conjunctivitis is the most common overall cause of infectious conjunctivitis and usually does not require treatment; the signs and symptoms at presentation are variable. Bacterial conjunctivitis is the second most common cause of infectious conjunctivitis, with most uncomplicated cases resolving in 1 to 2 weeks. Mattering and adherence of the eyelids on waking, lack of itching, and absence of a history of conjunctivitis are the strongest factors associated with bacterial conjunctivitis. Topical antibiotics decrease the duration of bacterial conjunctivitis and allow earlier return to school or work. Conjunctivitis secondary to sexually transmitted diseases such as chlamydia and gonorrhea requires systemic treatment in addition to topical antibiotic therapy. Allergic conjunctivitis is encountered in up to 40% of the population, but only a small proportion of these individuals seek medical help; itching is the most consistent sign in allergic conjunctivitis, and treatment consists of topical antihistamines and mast cell inhibitors. CONCLUSIONS AND RELEVANCE The majority of cases in bacterial conjunctivitis are self-limiting and no treatment is necessary in uncomplicated cases. However, conjunctivitis caused by gonorrhea or chlamydia and conjunctivitis in contact lens wearers should be treated with antibiotics. Treatment for viral conjunctivitis is supportive. Treatment with antihistamines and mast cell stabilizers alleviates the symptoms of allergic conjunctivitis.
引用
收藏
页码:1721 / 1729
页数:9
相关论文
共 86 条
[11]   Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model [J].
Butrus, S ;
Greiner, JV ;
Discepola, M ;
Finegold, I .
CLINICAL THERAPEUTICS, 2000, 22 (12) :1462-1472
[12]   3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children [J].
Cochereau, Isabelle ;
Meddeb-Ouertani, Amel ;
Khairallah, Moncef ;
Amraoui, Abdelouahed ;
Zaghloul, Khalid ;
Pop, Mihai ;
Delval, Laurent ;
Pouliquen, Pascale ;
Tandon, Radhika ;
Garg, Prashant ;
Goldschmidt, Pablo ;
Bourcier, Tristan .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (04) :465-469
[13]  
Cronau H, 2010, AM FAM PHYSICIAN, V81, P137
[14]   Microbiologic efficacy of 3-day treatment with azithromycin 1.5% eyedrops for purulent bacterial conjunctivitis [J].
Denis, F. ;
Chaumeil, C. ;
Goldschmidt, P. ;
Delval, L. ;
Pouliquen, P. ;
Cochereali, D. ;
Chainier, D. ;
De Barbeyrac, B. .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2008, 18 (06) :858-868
[15]   Comparative evaluation of olopatadine ophthalmic solution (0.1%) versus ketorolac ophthalmic solution (0.5%) using the provocative antigen challenge model [J].
Deschenes, J ;
Discepola, M ;
Abelson, M .
ACTA OPHTHALMOLOGICA SCANDINAVICA, 1999, 77 :47-52
[16]   Efficacy and safety of ketorolac tromethamine 0.5% and levoeabastine 0.05%: A multicenter comparison in patients with seasonal allergic conjunctivitis [J].
Donshik, PC ;
Pearlman, D ;
Pinnas, J ;
Raizman, MB ;
Tauber, J ;
Tinkelman, D ;
Walters, TR .
ADVANCES IN THERAPY, 2000, 17 (02) :94-102
[17]  
Epling J., 2010, CLIN EVID, V2010
[18]  
Epling John, 2005, Clin Evid, P756
[19]  
FITCH CP, 1989, OPHTHALMOLOGY, V96, P1215
[20]   Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus [J].
Freidlin, Julie ;
Acharya, Nisha ;
Lietman, Thomas M. ;
Cevallos, Vicky ;
Whitcher, John P. ;
Margolis, Todd P. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (02) :313-315